News & Updates

Show Multimedia Only

Indoor air purifiers good for children’s pulmonary health

12 Dec 2024

Prolonged air purification in indoor environments helps alleviate airway inflammation in children, a study has shown.

Indoor air purifiers good for children’s pulmonary health

12 Dec 2024

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

10 Dec 2024

The post-pandemic burden of COVID-19 remains significant in adults. Four studies from IDWeek 2024 highlight the benefits of nirmatrelvir-ritonavir (NMV/r) for high-risk adults with SARS-CoV-2 immunity and link chronic conditions to COVID-19 hospitalization. Identifying high-risk patients and using NMV/r in outpatient settings can reduce severe outcomes.

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

10 Dec 2024

BPaLM regimen looks good for drug-resistant TB in children, adults

09 Dec 2024 by

A therapeutic regimen comprising bedaquiline, pretomanid, linezolid, and moxifloxacin (BPaLM) appears to work against drug-resistant tuberculosis (TB) both in paediatric and adult patients, according to two small studies conducted in Indonesia.

BPaLM regimen looks good for drug-resistant TB in children, adults

09 Dec 2024

Clinical considerations for patients at high risk for progression to severe COVID-19

07 Dec 2024

COVID-19 has not gone away. New contagious variants continue to be a leading cause of death, with underlying conditions still influencing the risk of COVID-19 hospitalizations, said Dr Ali Hassoun, Clinical Professor of Medicine and infectious disease specialist at Crestwood Medical Center, Huntsville, Alabama, US, who spoke at a Pfizer-sponsored session during IDWeek 2024.

Clinical considerations for patients at high risk for progression to severe COVID-19

07 Dec 2024

RSV places strain on HK’s public health system, but vaccination reduces burden

06 Dec 2024 by

Respiratory syncytial virus (RSV)-associated infections in older adults impose a substantial economic burden on Hong Kong’s public health system, but the good news is that this burden may be mitigated by vaccination.

RSV places strain on HK’s public health system, but vaccination reduces burden

06 Dec 2024

Benralizumab offers relief during eosinophilic asthma, COPD flare-ups

04 Dec 2024 by

A single subcutaneous injection of benralizumab, administered alone or in combination with glucocorticoids, helps minimize treatment failure and improve symptoms in patients with an eosinophilic exacerbation of asthma or chronic obstructive pulmonary disorder (COPD), as shown in the phase II ABRA trial.

Benralizumab offers relief during eosinophilic asthma, COPD flare-ups

04 Dec 2024

Why not metformin for long COVID in non-diabetics?

03 Dec 2024 by

Metformin prescribed within a week of SARS-CoV-2 infection was associated with a 53-percent reduction in long COVID or death over 6 months in patients without diabetes or prediabetes, as shown in a simulation study presented at IDWeek 2024.

Why not metformin for long COVID in non-diabetics?

03 Dec 2024

Triple therapy improves health status of COPD patients in real-world setting

30 Nov 2024 by

Treatment with budesonide/glycopyrronium/formoterol (BGF), a triple therapy delivered via metered-dose inhaler (MDI), improves health status in Chinese patients with chronic obstructive pulmonary disease (COPD), based on real-world data presented at APSR 2024.

Triple therapy improves health status of COPD patients in real-world setting

30 Nov 2024

CPET is most analysed tool for assessing functionality before surgery

29 Nov 2024

Among the many tools being used to assess functional capacity prior to elective noncardiac surgery, cardiopulmonary exercise testing (CPET) is the most studied, followed by field walking tests, according to a study. Moreover, most research also focuses on only one aspect of validity.

CPET is most analysed tool for assessing functionality before surgery

29 Nov 2024

BGF inhaler safe to use in COPD patients

25 Nov 2024 by

Treatment with budesonide/glycopyrrolate/formoterol (BGF) using a metered dose inhaler (MDI) demonstrates an acceptable safety profile and improves symptoms in patients with chronic obstructive pulmonary disease (COPD) in a real-world clinical setting, results of the TORES study have shown.

BGF inhaler safe to use in COPD patients

25 Nov 2024

News & Updates

Filter by Specialty:

Specialty:

Indoor air purifiers good for children’s pulmonary health

Indoor air purifiers good for children’s pulmonary health

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

Nirmatrelvir-ritonavir efficacy and risk factors for COVID-19 hospitalization

BPaLM regimen looks good for drug-resistant TB in children, adults

BPaLM regimen looks good for drug-resistant TB in children, adults

Clinical considerations for patients at high risk for progression to severe COVID-19

Clinical considerations for patients at high risk for progression to severe COVID-19

RSV places strain on HK’s public health system, but vaccination reduces burden

RSV places strain on HK’s public health system, but vaccination reduces burden

Benralizumab offers relief during eosinophilic asthma, COPD flare-ups

Benralizumab offers relief during eosinophilic asthma, COPD flare-ups

Why not metformin for long COVID in non-diabetics?

Why not metformin for long COVID in non-diabetics?

Triple therapy improves health status of COPD patients in real-world setting

Triple therapy improves health status of COPD patients in real-world setting

CPET is most analysed tool for assessing functionality before surgery

CPET is most analysed tool for assessing functionality before surgery

BGF inhaler safe to use in COPD patients

BGF inhaler safe to use in COPD patients